Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
Over the last century, the definitions of pharmaceutical drug and drug discovery have changed considerably. Evolving from an almost exclusively serendipitous approach, drug discovery nowadays involves several distinct, yet sometimes interconnected stages aimed at obtaining molecules able to interact...
Main Authors: | Luca G. Mureddu, Geerten W. Vuister |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.834453/full |
Similar Items
-
Applications of Solution NMR in Drug Discovery
by: Li Shi, et al.
Published: (2021-01-01) -
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
by: Tianming Zhao, et al.
Published: (2023-01-01) -
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
by: Namdev S. Togre, et al.
Published: (2022-09-01) -
Development of venetoclax for therapy of lymphoid malignancies
by: Zhu H, et al.
Published: (2017-03-01) -
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
by: Sheikh Mohammed Arif, et al.
Published: (2022-03-01)